Kestra Advisory Services’s Crinetics Pharmaceuticals CRNX Stock Holding History

Kestra Advisory Services’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$136K	Buy
2025 Q1	–	Sell
2024 Q4	$265K	Buy
2024 Q3	$261K	Buy
2024 Q2	$228K	Buy
2024 Q1	–	Sell
2023 Q4	$263K	Sell
2023 Q3	$221K	Buy